AVANIR PHARMACEUTICALS INC - 005348P40
Detailed investor-level table based on 13F positions.
Methodology:
Market value and % of portfolio use SEC reported VALUE ($000).
For PUT/CALL positions this reflects reported underlying exposure, not premium cash paid/received.
Details.
Rows: 0
| Investor | History | Status | Shares held | Market value ($000) | % of portfolio | Previous % | Rank | Change in shares | % change in shares | Source | Date reported |
|---|---|---|---|---|---|---|---|---|---|---|---|
| INGALLS & SNYDER LLC | History | Reduced | 10,294,143 | 58,058 | 2.85% | 2.18% | 1 | -790,300 | -7.13% | Q2 2014 | Jul 30, 2014 |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | History | Closed out | 0 | 0 | — | 0.0% | — | -42,537 | -100.0% | Q1 2014 | May 15, 2014 |